Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for in vitro induction of human amniotic mesenchymal stem cells (hAMSCs) differentiated into insulin-secreting cells (ISCs)

A technology of insulin secretion and mesenchymal stem cells, applied in the field of insulin secretion cells, can solve problems such as immune rejection and technical difficulty limitations

Inactive Publication Date: 2012-03-28
AFFILIATED HOSPITAL OF ZUNYI MEDICAL COLLEGE
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although pancreas or islet transplantation is expected to be an ideal method for the treatment of type 1 diabetes, it is subject to many limitations due to issues such as tissue supply, immune rejection, and technical difficulties.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0013] A method of inducing human amniotic mesenchymal stem cells to differentiate into insulin-secreting cells in vitro of the present invention comprises the following steps:

[0014] (1) Isolation of hAMSCs: Cut the human amniotic membrane into pieces, add 0.05% trypsin digestion solution containing 0.02% EDTA, rotate and digest at 37°C, 200 rpm for 10 minutes, discard the supernatant; 37°C, 200 rpm spinning for 30 minutes, discard the supernatant, keep the undigested amnion fragments, wash twice with D-Hank's solution, add 0.75 mg / ml collagenase containing 0.075 mg / ml DNase I , at 37°C, 200 rpm for about 2 h until the tissue was completely digested, filtered through a 300-mesh steel mesh, collected the cell filtrate, centrifuged at 1500 rpm for 10 minutes, and collected the cell pellet, namely the original hAMSCs;

[0015] (2) Purification of hAMSCs: The isolated original hAMSCs were resuspended in low-glucose-DMEM medium (purchased from Gibco, catalog number: 31600-026; c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for the in vitro induction of hAMSCs differentiated into ISCs. According to the method, the extracted hAMSCs are cultured for 7 days by a serum-free high sugar-DMEM induction medium containing niacinamide of 10mmol / L and an N2 supplement. The hAMSCs induced by the method of the invention express insulin gene mRNA and PDX-1 gene mRNA, and the content of insulin in the supernatant of the culture reaches above 330muIU / ml; and the method of the invention allows the in vitro induction of the hAMSCs differentiated into the ISCs to be realized.

Description

technical field [0001] The invention relates to a method for inducing human amniotic mesenchymal stem cells to differentiate into insulin-secreting cells in vitro. Background technique [0002] Human amniotic mesenchymal stem cells (hAMSCs) have the advantages of multilineage differentiation, low immunogenicity, abundant sources, easy enrichment, strong expansion ability, and no medical ethical issues involved. It has broad application prospects. It has been proved that hAMSCs can differentiate into endothelial and hepatic epithelial cells, cardiomyocyte-like cells, neuron-like cells, osteoblasts, etc. under appropriate induction conditions, but whether they can differentiate into insulin-secreting pancreatic B cells has not been found so far. introduce. [0003] The occurrence of type 1 diabetes is related to genetic factors, environmental factors and immune mechanism, and its fundamental etiology and pathogenesis is insufficient insulin secretion caused by the destructio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/071
Inventor 方宁陈代雄赵玉洁
Owner AFFILIATED HOSPITAL OF ZUNYI MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com